Preliminary scientific tests show conolidine could inhibit precise ion channels, minimizing neuronal excitability and limiting discomfort alerts. This system is particularly appropriate in neuropathic discomfort, where by irregular signaling leads to persistent discomfort. In addition, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integral to suffering notion... https://harlanm936yff7.blogofchange.com/profile